Be Glad You Didn’t Sell Affymetrix’s Earnings Miss. Its Returns Are Evidence Of Its Recovery

[at Seeking Alpha] – Investors who sold Affymetrix ( AFFX ) after the earnings miss last week are missing something themselves: this Life Sciences biotech company is turning around. In 2013 AFFX more than doubled year-over-year … more

View todays social media effects on AFFX

View the latest stocks trending across Twitter. Click to view dashboard

See who Affymetrix is hiring next, click here to view